Quick Answer
REVELATION BIOSCIENCES, INC. reported Stockholders Equity of $8.86 million for the year ending 2025.
- REVELATION BIOSCIENCES, INC. showed an increase of +88.2% in Stockholders Equity from 2024 to 2025.
- This data is from REVELATION BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2020: $3.41 million | Q1 2021: $8.91 million | Q2 2021: $6.57 million | Q3 2021: $3.66 million | Q1 2022: -$98.5 thousand | Q2 2022: -$1.84 million | Q3 2022: $2.23 million | Q1 2023: $10.02 million | Q2 2023: $11.41 million | Q3 2023: $8.82 million | Q1 2024: $9.47 million | Q2 2024: $1.14 million | Q3 2024: $2.67 million | Q1 2025: $2.88 million | Q2 2025: $3.83 million | Q3 2025: $11.00 million.
- Over the full 7 years of available data (2019 to 2025), REVELATION BIOSCIENCES, INC.'s Stockholders Equity has grown by 243,667.8%.
- Historical annual values: Fiscal year 2025: $8.86 million | Fiscal year 2024: $4.71 million | Fiscal year 2023: $6.65 million | Fiscal year 2022: $1.05 million | Fiscal year 2021: -$99.5 thousand | Fiscal year 2020: $3.41 million | Fiscal year 2019: -$3.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: